Detalhe da pesquisa
1.
Eligibility for CAR T-cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL.
Am J Hematol
; 94(4): E117-E116, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663774